OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis
Lin Chen, Dan‐Qian Chen, Jingru Liu, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 3, pp. 1-18
Open Access | Times Cited: 94
Lin Chen, Dan‐Qian Chen, Jingru Liu, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 3, pp. 1-18
Open Access | Times Cited: 94
Showing 1-25 of 94 citing articles:
Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease
Nadja Paeslack, Maximilian Mimmler, Stefanie I. Becker, et al.
Amino Acids (2022) Vol. 54, Iss. 10, pp. 1339-1356
Open Access | Times Cited: 84
Nadja Paeslack, Maximilian Mimmler, Stefanie I. Becker, et al.
Amino Acids (2022) Vol. 54, Iss. 10, pp. 1339-1356
Open Access | Times Cited: 84
The role and mechanism of histone lactylation in health and diseases
Yumei Xie, Hongxia Hu, Maoting Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 77
Yumei Xie, Hongxia Hu, Maoting Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 77
Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2847-2892
Open Access | Times Cited: 47
Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2847-2892
Open Access | Times Cited: 47
Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation
Jingru Liu, Hua Miao, Deqiang Deng, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 3, pp. 909-922
Closed Access | Times Cited: 136
Jingru Liu, Hua Miao, Deqiang Deng, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 3, pp. 909-922
Closed Access | Times Cited: 136
Chronic kidney disease: Biomarker diagnosis to therapeutic targets
Yanni Wang, Shixing Ma, Yuanyuan Chen, et al.
Clinica Chimica Acta (2019) Vol. 499, pp. 54-63
Closed Access | Times Cited: 113
Yanni Wang, Shixing Ma, Yuanyuan Chen, et al.
Clinica Chimica Acta (2019) Vol. 499, pp. 54-63
Closed Access | Times Cited: 113
Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis
Ya‐Long Feng, Dan‐Qian Chen, Nosratola D. Vaziri, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 1, pp. 54-78
Open Access | Times Cited: 112
Ya‐Long Feng, Dan‐Qian Chen, Nosratola D. Vaziri, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 1, pp. 54-78
Open Access | Times Cited: 112
Shotgun metagenomics reveals both taxonomic and tryptophan pathway differences of gut microbiota in major depressive disorder patients
Wentao Lai, Wenfeng Deng, Shu‐xian Xu, et al.
Psychological Medicine (2019) Vol. 51, Iss. 1, pp. 90-101
Closed Access | Times Cited: 112
Wentao Lai, Wenfeng Deng, Shu‐xian Xu, et al.
Psychological Medicine (2019) Vol. 51, Iss. 1, pp. 90-101
Closed Access | Times Cited: 112
Characterizing the gut microbiota in patients with chronic kidney disease
Xiaofang Hu, Shaxi Ouyang, Yuhong Xie, et al.
Postgraduate Medicine (2020) Vol. 132, Iss. 6, pp. 495-505
Closed Access | Times Cited: 82
Xiaofang Hu, Shaxi Ouyang, Yuhong Xie, et al.
Postgraduate Medicine (2020) Vol. 132, Iss. 6, pp. 495-505
Closed Access | Times Cited: 82
Alteration of gut microbial profile in patients with diabetic nephropathy
Xi Du, Jia Liu, Xue Yu, et al.
Endocrine (2021) Vol. 73, Iss. 1, pp. 71-84
Closed Access | Times Cited: 65
Xi Du, Jia Liu, Xue Yu, et al.
Endocrine (2021) Vol. 73, Iss. 1, pp. 71-84
Closed Access | Times Cited: 65
Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
Shanshan Li, Qian Sun, Meng-Ru Hua, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 61
Shanshan Li, Qian Sun, Meng-Ru Hua, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 61
Epithelial–mesenchymal transition in organ fibrosis development: current understanding and treatment strategies
Lexin Liu, Qizhe Sun, Frank M. Davis, et al.
Burns & Trauma (2022) Vol. 10
Open Access | Times Cited: 60
Lexin Liu, Qizhe Sun, Frank M. Davis, et al.
Burns & Trauma (2022) Vol. 10
Open Access | Times Cited: 60
The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword
Eman Wehedy, Ibrahim F. Shatat, Souhaila Al Khodor
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 54
Eman Wehedy, Ibrahim F. Shatat, Souhaila Al Khodor
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 54
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
Xiao-Yong Yu, Qian Sun, Yamei Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 51
Xiao-Yong Yu, Qian Sun, Yamei Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 51
Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling
Yue-Qi Tan, Yanni Wang, Hao-Yu Feng, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 30-41
Closed Access | Times Cited: 46
Yue-Qi Tan, Yanni Wang, Hao-Yu Feng, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 30-41
Closed Access | Times Cited: 46
The Footprint of Kynurenine Pathway in Cardiovascular Diseases
Moein Ala, Seyed Parsa Eftekhar
International Journal of Tryptophan Research (2022) Vol. 15
Open Access | Times Cited: 42
Moein Ala, Seyed Parsa Eftekhar
International Journal of Tryptophan Research (2022) Vol. 15
Open Access | Times Cited: 42
Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan‐produced indole metabolites
Hua Miao, Yanni Wang, Xiao‐Yong Yu, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 1, pp. 162-179
Closed Access | Times Cited: 38
Hua Miao, Yanni Wang, Xiao‐Yong Yu, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 1, pp. 162-179
Closed Access | Times Cited: 38
The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis
Na Ren, Wenfeng Wang, Liang Zou, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Na Ren, Wenfeng Wang, Liang Zou, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment
Yang Li, Xinhuan Su, Ying Gao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 6, pp. 165764-165764
Open Access | Times Cited: 67
Yang Li, Xinhuan Su, Ying Gao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 6, pp. 165764-165764
Open Access | Times Cited: 67
Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy
Dan Liu, Lin Chen, Hui Zhao, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 117, pp. 108990-108990
Open Access | Times Cited: 66
Dan Liu, Lin Chen, Hui Zhao, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 117, pp. 108990-108990
Open Access | Times Cited: 66
An integrated fecal microbiome and metabolome in the aged mice reveal anti-aging effects from the intestines and biochemical mechanism of FuFang zhenshu TiaoZhi(FTZ)
Shenghua Piao, Ziqin Zhu, Tan Shuyu, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109421-109421
Open Access | Times Cited: 62
Shenghua Piao, Ziqin Zhu, Tan Shuyu, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109421-109421
Open Access | Times Cited: 62
New therapeutic targets in chronic kidney disease progression and renal fibrosis
Sandra Rayego‐Mateos, José Manuel Valdivielso
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 7, pp. 655-670
Closed Access | Times Cited: 62
Sandra Rayego‐Mateos, José Manuel Valdivielso
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 7, pp. 655-670
Closed Access | Times Cited: 62
Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma
Hui Zhao, Lin Chen, Yang Tian, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 60
Hui Zhao, Lin Chen, Yang Tian, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 60
Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation
Hua Miao, Gang Cao, Xiaqing Wu, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 15, pp. 3415-3435
Open Access | Times Cited: 56
Hua Miao, Gang Cao, Xiaqing Wu, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 15, pp. 3415-3435
Open Access | Times Cited: 56
Rhubarb Enema Improved Colon Mucosal Barrier Injury in 5/6 Nephrectomy Rats May Associate With Gut Microbiota Modification
Chunlan Ji, Yusheng Deng, Aicheng Yang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 52
Chunlan Ji, Yusheng Deng, Aicheng Yang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 52
Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
Liang-Pu Luo, Ping Suo, Lili Ren, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 51
Liang-Pu Luo, Ping Suo, Lili Ren, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 51
